By Elric Langton | 2nd October 2021
The CEO of SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, was gracious enough to put aside a few minutes to discuss Thursday’s significant update on its commercialisation plans for AxisBiotix-Ps™, its probiotic food supplement. I was hoping for a slot on Thursday, but James Bond 007…